RYLPF (Koninklijke Philips NV) Change In Receivables: $6 Mil (TTM As of Mar. 2026)


RYLPF Koninklijke Philips NV RYLPF
72 GF Score
Price $28.01
GF Value $25.39
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Koninklijke Philips NV Change In Receivables?

Koninklijke Philips NV RYLPF +2.21% 72 Change In Receivables is $6 Mil as of Mar. 2026. GuruFocus rates RYLPF with a GF Score™ of 72/100 and a GF Value™ of $25.39 (Fairly Valued). The stock has 5 warning signs investors should review.

Koninklijke Philips NV's change in receivables for the quarter that ended in Mar. 2026 was $253 Mil. It means Koninklijke Philips NV's Accounts Receivable declined by $253 Mil from Dec. 2025 to Mar. 2026 .

Koninklijke Philips NV's change in receivables for the fiscal year that ended in Dec. 2025 was $-62 Mil. It means Koninklijke Philips NV's Accounts Receivable increased by $62 Mil from Dec. 2024 to Dec. 2025 .

Koninklijke Philips NV's Accounts Receivable for the quarter that ended in Mar. 2026 was $3,771 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Koninklijke Philips NV's Days Sales Outstanding for the three months ended in Mar. 2026 was 76.22.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Koninklijke Philips NV's liquidation value for the three months ended in Mar. 2026 was $-10,699 Mil.


Koninklijke Philips NV  (OTCPK:RYLPF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Koninklijke Philips NV's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=3771.098/4514.451*91
=76.22

2. In Ben Graham's calculation of liquidation value, Koninklijke Philips NV's accounts receivable are only considered to be worth 75% of book value:

Koninklijke Philips NV's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2996.532-18321.387+0.75 * 3771.098+0.5 * 3595.376
=-10,699

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Koninklijke Philips NV Change In Receivables Related Terms


Koninklijke Philips NV Change In Receivables Historical Data

* Premium members only.

The historical data trend for Koninklijke Philips NV's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koninklijke Philips NV Change In Receivables Chart

Koninklijke Philips NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -96.05 -361.23 288.99 -6.28 -62.06

Koninklijke Philips NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 172.97 -38.06 -4.70 -204.92 253.18
RYLPF
72GF Score
Koninklijke Philips NV RYLPF
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Koninklijke Philips NV Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $6 Mil mean?
Koninklijke Philips NV (RYLPF) has a Change In Receivables of $6 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Koninklijke Philips NV and its competitors.
Is Koninklijke Philips NV's Change In Receivables too high?
Koninklijke Philips NV's current Change In Receivables is $6 Mil. Overall, Koninklijke Philips NV has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Change In Receivables compare to ABT and SYK?
Koninklijke Philips NV's Change In Receivables of $6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Koninklijke Philips NV and its competitors. Koninklijke Philips NV's current Change In Receivables is $6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.39, compared to a current price of $28.01 — trading 10.3% above its estimated fair value. The current Change In Receivables is $6 Mil. Koninklijke Philips NV's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Change In Receivables is $6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued. The current stock price of $28.01 is trading 10.3% above its estimated GF Value™ of $25.39. GuruFocus considers Koninklijke Philips NV to be Fairly Valued.

Key valuation signals for RYLPF:

  • Change In Receivables: $6 Mil
  • GF Value™: $25.39 vs. price of $28.01 (10.3% above fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Koninklijke Philips NV Business Description

Address Prinses Irenestraat 59, Amsterdam, NLD, 1077 WV
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
72GF Score

Get the complete analysis for RYLPF

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.01
Price
$25.39
GF Value